Thursday, November 25, 2021

ITC starts clinical trials of nasal spray for COVID-19 prevention

ITC starts clinical trials of nasal spray for COVID-19 prevention Developed by scientists at ITC Life Sciences and Technology Centre (LSTC), Bengaluru, the company plans to market the nasal spray under the Savlon brand once it gets all the requisite regulatory approvals, according to sources.

from Moneycontrol Business News https://ift.tt/32yCAMb
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

US stock: S&P 500 ends lower as investors weigh data, Middle East tensions

The S&P 500's streak came to an end, falling from its peak as weaker retail sales suggested caution among consumers. Despite a stron...